TLR9 activation is defective in common variable immune deficiency.
about
DOCK8 functions as an adaptor that links TLR-MyD88 signaling to B cell activationUpdate in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditionsToll-like receptor 9, transmembrane activator and calcium-modulating cyclophilin ligand interactor, and CD40 synergize in causing B-cell activation.Common variable immunodeficiency presenting as herpes simplex virus encephalitis.Transmembrane activator and calcium-modulating cyclophilin ligand interactor mutations in common variable immunodeficiency: clinical and immunologic outcomes in heterozygotes.Granulomatous disease in common variable immunodeficiency.Nodular regenerative hyperplasia in common variable immunodeficiency.Toll-like receptor 7 and 9 defects in common variable immunodeficiency.Autoimmunity in common variable immunodeficiency.Role of B cells in common variable immune deficiency.Autoimmunity and inflammation in X-linked agammaglobulinemia.The C104R mutant impairs the function of transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI) through haploinsufficiencyDisturbed homeostasis and multiple signaling defects in the peripheral blood B-cell compartment of patients with severe chronic sarcoidosisRegulation of mucosal IgA responses: lessons from primary immunodeficiencies.IgH sequences in common variable immune deficiency reveal altered B cell development and selection.TLR-mediated B cell defects and IFN-α in common variable immunodeficiencyToll-like receptor 4-, 7-, and 8-activated myeloid cells from patients with X-linked agammaglobulinemia produce enhanced inflammatory cytokines.Toll-like receptor function in primary B cell defects.Toll-like receptor signaling in primary immune deficiencies.TACI mutation in common variable immunodeficiency and IgA deficiency.Common variable immunodeficiency: an updateCD19 controls Toll-like receptor 9 responses in human B cellsHigh serum levels of BAFF, APRIL, and TACI in common variable immunodeficiency.CVID-associated TACI mutations affect autoreactive B cell selection and activation.Memory B cells in common variable immunodeficiency: clinical associations and sex differences.The role of costimulation in antibody deficiencies: ICOS and common variable immunodeficiency.Common variable immunodeficiency (CVID): exploring the multiple dimensions of a heterogeneous disease.Toll-like receptors' pathway disturbances are associated with increased susceptibility to infections in humans.Common variable immunodeficiency in adults: current diagnostic protocol and laboratory measures.Cytokines in common variable immunodeficiency as signs of immune dysregulation and potential therapeutic targets - a review of the current knowledge.Primary blood neutrophils express a functional cell surface Toll-like receptor 9.The role of toll-like receptors in B-cell development and immunopathogenesis of common variable immunodeficiency.Evaluation of Known Defective Signaling-Associated Molecules in Patients Who Primarily Diagnosed as Common Variable Immunodeficiency.Naturally occurring mutation affecting the MyD88-binding site of TNFRSF13B impairs triggering of class switch recombination.Mitogen-induced B-cell proliferation activates Chk2-dependent G1/S cell cycle arrestTLR9 stimulation of B-cells induces transcription of p53 and prevents spontaneous and irradiation-induced cell death independent of DNA damage responses. Implications for Common variable immunodeficiency.Common variable immunodeficiency revisited: normal generation of naturally occurring dendritic cells that respond to Toll-like receptors 7 and 9.Functional analysis of transmembrane activator and calcium-modulating cyclophilin ligand interactor (TACI) mutations associated with common variable immunodeficiency.A sticky story for signal transducer and activator of transcription 3 in platelets.Impaired pneumovax-23-induced monocyte-derived cytokine production in patients with common variable immunodeficiency.
P2860
Q24321675-A34CA76F-8CCC-4A6B-9EEA-73BBD5719C66Q28240370-50526A24-C2A2-4794-8E5B-52F642467A97Q30425171-F6254138-98A3-4E34-8C78-E7E7AED2C489Q30428549-C3304A22-29F2-48D8-914E-314AD022D974Q33377299-7367BDC6-9D14-435D-B279-0EBAD0630A93Q33386034-5CB9B81D-D27E-43C9-A61C-DDA3C466D9B0Q33405963-E9F3CFFE-DE2C-4008-8D5A-D5D5FADA9C10Q34013669-4BA7AD1B-3C96-414E-8B99-9A6E762F0BF7Q34056308-54297874-21CB-4528-8056-8FB49FCA99D4Q34071102-2DDFB005-4103-4879-A75F-E895992CC5D7Q34146476-ABE46813-7D23-4F59-AD88-E811EC27A350Q35065333-4D0324ED-4AD9-4BDA-A800-E7E73052B314Q35138825-926A954B-9611-4293-91B1-D870F9359E4BQ35619309-4482B0D0-6BD0-4705-8329-4E9E1DDFD9F6Q36096339-9137430C-8EEA-419B-94DB-AB5A087F1981Q36190388-F65E18CD-4D0C-4C29-A498-407A1F052B76Q36190423-5C55E8C5-8F6B-4597-8D56-DC66ACFD3A42Q36190430-F1299771-D2D2-4AA4-9E77-DEE52878F837Q36238886-9811F720-D16E-4A92-A09E-5E8B42B7AA32Q36561218-A7DFAAAA-1446-4357-B549-ACE8D4CD51C0Q36633106-CE39E45C-95C5-4FC1-8E4F-1AA0678F8480Q36665253-0853681A-B967-409C-8261-BD97DD2F18BEQ36800138-99F07059-EE51-45CC-A3C7-6183050E89E9Q37206886-9A2C211A-73F1-48D0-A8DE-EB87A264A81FQ37216274-7880D97B-CCFD-4726-A8EF-21F58E05BA05Q37474910-3807BEBE-541B-456A-AE0B-3CB7A3FEC932Q37980927-D70021AD-C730-4A99-91C8-4656B00F7A4AQ38140711-B29C2EAC-5EEC-47B3-B233-E422FCBCC581Q38152821-4D4FE003-DB3E-4540-BBBE-57F818914990Q38211700-8F8CF7BD-20D0-453B-B709-97E3981894EDQ38315378-BE18A5F5-18D1-4228-BA87-9CB09DE3924EQ38665495-416C43CA-BE77-4BB4-B539-EFE05644E242Q38767112-61C3EB0B-CD10-49D7-A901-D0CB1F99AE1CQ40659511-3F6A1059-2BD1-403C-80E6-68CDB2827143Q41901371-3CF2CE32-33E8-4DAF-9C92-724A878A2EFAQ41991646-BC591613-FE19-4AFA-AD68-04F5DCE323D2Q42255402-63481FA2-9577-45EA-8F8E-5D4098B26591Q42771432-02BB3B90-B668-47CF-AE33-1E3741F1D6B5Q43125680-1402E569-64A5-4BA8-AFA0-51892C324D90Q43737162-4E117956-957E-448F-8C18-8643EAFE543D
P2860
TLR9 activation is defective in common variable immune deficiency.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
TLR9 activation is defective in common variable immune deficiency.
@en
TLR9 activation is defective in common variable immune deficiency.
@nl
type
label
TLR9 activation is defective in common variable immune deficiency.
@en
TLR9 activation is defective in common variable immune deficiency.
@nl
prefLabel
TLR9 activation is defective in common variable immune deficiency.
@en
TLR9 activation is defective in common variable immune deficiency.
@nl
P2093
P1476
TLR9 activation is defective in common variable immune deficiency.
@en
P2093
Adina K Knight
Atsushi Nakazawa
Laura Bauer
Lin Radigan
P304
P356
10.4049/JIMMUNOL.176.3.1978
P407
P577
2006-02-01T00:00:00Z